+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Continuous Subcutaneous Insulin Infusion Market Size, Share & Trends Analysis Report By Product, By Patient Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 6040983
Description Jump to:

Continuous Subcutaneous Insulin Infusion Market Growth & Trends

The global continuous subcutaneous insulin infusion market size is anticipated to reach USD 1.14 billion by 2030. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. The key drivers of the market include increasing number of diabetes population coupled with technological advancement in the field of diabetes care.

According to International Diabetes Federation (IDF), the total number of diabetic population is expected to grow by 51.0% from 463.0 million in 2019 to 700.0 million in 2045. Rising health expenditure and growing awareness about preventive care is expected to boost market growth. According to the IDF, the estimated total global health expenditure to diabetes was USD 760.0 billion and is projected to grow to USD 845.0 billion by 2045. Furthermore, rising government initiatives to spread the awareness about diabetes is propelling the adoption of advanced diabetes management devices. Australian government launched Australian National Diabetes Strategy 2016 to 2020. The strategy aims to trace country’s national response to this epidemic and inform how existing limited healthcare can be better targeted across all level of government.

Increasing number of product launches and advent of artificial intelligence in the market is boosting the growth. Many startups are transforming CSII therapy. These companies are taking initiatives to lessen the burden of diabetes with help of AI technology. They are leveraging technological advancement to improve market solutions like integrated insulin pumps, non-invasive insulin delivery systems, and closed-loop artificial pancreases.

Continuous Subcutaneous Insulin Infusion Market Report Highlights

  • The patch pump segment is expected to grow at the fastest CAGR of 10.2% over the forecast period, owing to the increasing demand for convenient, customizable insulin delivery solutions that cater to people with higher insulin requirements, such as those with Type 2 diabetes.
  • The diabetes type 1 segment held the largest market share of 82.1% in 2024, which can be attributed to the growing global prevalence of diabetes type 1, necessitating efficient and continuous insulin delivery solutions for better blood sugar management.
  • The diabetes type 2 segment is expected to grow at the fastest CAGR of 10.0% over the forecast period.
  • North America continuous subcutaneous insulin infusion market held the largest share of 39.2% in 2024, which can be attributed to the approval of advanced insulin pumps that feature meal detection technology and automatic insulin corrections, enhancing blood sugar control and making diabetes management more convenient for patients.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Patient Type
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Continuous Subcutaneous Insulin Infusion Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Continuous Subcutaneous Insulin Infusion Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Patch Pumps
4.4.1. Patch pumps market, 2018 - 2030 (USD Million)
4.4.2. Basal
4.4.2.1. Basal market, 2018 - 2030 (USD Million)
4.4.3. Bolus
4.4.3.1. Bolus market, 2018 - 2030 (USD Million)
4.4.4. Basal and Bolus
4.4.4.1. Basal and bolus market, 2018 - 2030 (USD Million)
4.5. Tethered Pumps
4.5.1. Tethered pumps market, 2018 - 2030 (USD Million)
4.5.2. Insulin Reservoir or Cartridges
4.5.2.1. Insulin reservoir or cartridges market, 2018 - 2030 (USD Million)
4.5.3. Insulin Set Insertion Devices
4.5.3.1. Insulin set insertion devices market, 2018 - 2030 (USD Million)
4.5.4. Battery
4.5.4.1. Battery market, 2018 - 2030 (USD Million)
Chapter 5. Continuous Subcutaneous Insulin Infusion Market: Patient Type Business Analysis
5.1. Patient Type Market Share, 2024 & 2030
5.2. Patient Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
5.4. Diabetes Type 1
5.4.1. Diabetes type 1 market, 2018 - 2030 (USD Million)
5.5. Diabetes Type 2
5.5.1. Diabetes type 2 market, 2018 - 2030 (USD Million)
Chapter 6. Continuous Subcutaneous Insulin Infusion Market: End Use Business Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals & Clinics
6.4.1. Hospitals & clinics market, 2018 - 2030 (USD Million)
6.5. Homecare
6.5.1. Homecare market, 2018 - 2030 (USD Million)
6.6. Laboratories
6.6.1. Laboratories market, 2018 - 2030 (USD Million)
Chapter 7. Continuous Subcutaneous Insulin Infusion Market: Regional Estimates & Trend Analysis by Product, Patient Type, and End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. U.S. continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. Canada continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. Mexico continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. UK continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. Germany continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. France continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. Italy continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Spain continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Denmark continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamic
7.5.8.2. Regulatory framework
7.5.8.3. Competitive insights
7.5.8.4. Sweden continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamic
7.5.9.2. Regulatory framework
7.5.9.3. Competitive insights
7.5.9.4. Norway continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Japan continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. China continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamic
7.6.4.2. Regulatory framework
7.6.4.3. Competitive insights
7.6.4.4. India continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamic
7.6.5.2. Regulatory framework
7.6.5.3. Competitive insights
7.6.5.4. Australia continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamic
7.6.6.2. Regulatory framework
7.6.6.3. Competitive insights
7.6.6.4. South Korea continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamic
7.6.7.2. Regulatory framework
7.6.7.3. Competitive insights
7.6.7.4. Thailand continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. Brazil continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Argentina continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamic
7.8.2.2. Regulatory framework
7.8.2.3. Competitive insights
7.8.2.4. South Africa continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamic
7.8.3.2. Regulatory framework
7.8.3.3. Competitive insights
7.8.3.4. Saudi Arabia continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamic
7.8.4.2. Regulatory framework
7.8.4.3. Competitive insights
7.8.4.4. UAE continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamic
7.8.5.2. Regulatory framework
7.8.5.3. Competitive insights
7.8.5.4. Kuwait continuous subcutaneous insulin infusion market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Medtronic
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. F. Hoffmann-La Roche Ltd
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. ZEALAND PHARMA
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. CeQur Simplicity
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Insulet Corporation
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. YPSOMED
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. B. Braun SE
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. BD (Becton, Dickinson and Company)
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global continuous subcutaneous insulin infusion market, by region, 2018 - 2030 (USD Million)
Table 4. Global continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 5. Global continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 6. Global continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 7. North America continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
Table 8. North America continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 9. North America continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 10. North America continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 11. U.S. continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 12. U.S. continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 13. U.S. continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 14. Canada continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 15. Canada continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 16. Canada continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 17. Mexico continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 18. Mexico continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 19. Mexico continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 20. Europe continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
Table 21. Europe continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 22. Europe continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 23. Europe continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 24. UK continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 25. UK continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 26. UK continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 27. Germany continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 28. Germany continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 29. Germany continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 30. France continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 31. France continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 32. France continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 33. Italy continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 34. Italy continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 35. Italy continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 36. Spain continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 37. Spain continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 38. Spain continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 39. Denmark continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 40. Denmark continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 41. Denmark continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 42. Sweden continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 43. Sweden continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 44. Sweden continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 45. Norway continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 46. Norway continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 47. Norway continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 48. Asia Pacific continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
Table 49. Asia Pacific continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 50. Asia Pacific continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 51. Asia Pacific continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 52. Japan continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 53. Japan continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 54. Japan continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 55. China continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 56. China continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 57. China continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 58. India continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 59. India continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 60. India continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 61. Australia continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 62. Australia continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 63. Australia continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 64. South Korea continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 65. South Korea continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 66. South Korea continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 67. Thailand continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 68. Thailand continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 69. Thailand continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 70. Latin America continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
Table 71. Latin America continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 72. Latin America continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 73. Latin America continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 74. Brazil continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 75. Brazil continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 76. Brazil continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 77. Argentina continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 78. Argentina continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 79. Argentina continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa continuous subcutaneous insulin infusion market, by country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 84. South Africa continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 85. South Africa continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 86. South Africa continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 90. UAE continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 91. UAE continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 92. UAE continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
Table 93. Kuwait continuous subcutaneous insulin infusion market, by product, 2018 - 2030 (USD Million)
Table 94. Kuwait continuous subcutaneous insulin infusion market, by patient type, 2018 - 2030 (USD Million)
Table 95. Kuwait continuous subcutaneous insulin infusion market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Continuous subcutaneous insulin infusion market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product and patient type outlook (USD Million)
Fig. 10 End use outlook
Fig. 11 Competitive landscape
Fig. 12 Continuous subcutaneous insulin infusion market dynamics
Fig. 13 Continuous subcutaneous insulin infusion market: Porter’s five forces analysis
Fig. 14 Continuous subcutaneous insulin infusion market: PESTLE analysis
Fig. 15 Continuous subcutaneous insulin infusion market: Product segment dashboard
Fig. 16 Continuous subcutaneous insulin infusion market: Product market share analysis, 2024 & 2030
Fig. 17 Patch pumps market, 2018 - 2030 (USD Million)
Fig. 18 Tethered pumps market, 2018 - 2030 (USD Million)
Fig. 19 Continuous subcutaneous insulin infusion market: Patient type segment dashboard
Fig. 20 Continuous subcutaneous insulin infusion market: Patient type market share analysis, 2024 & 2030
Fig. 21 Diabetes type 1 market, 2018 - 2030 (USD Million)
Fig. 22 Diabetes type 2 market, 2018 - 2030 (USD Million)
Fig. 23 Continuous subcutaneous insulin infusion market: End use segment dashboard
Fig. 24 Continuous subcutaneous insulin infusion market: End use market share analysis, 2024 & 2030
Fig. 25 Hospitals & clinics market, 2018 - 2030 (USD Million)
Fig. 26 Homecare market, 2018 - 2030 (USD Million)
Fig. 27 Laboratories market, 2018 - 2030 (USD Million)
Fig. 28 Continuous subcutaneous insulin infusion market revenue, by region
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 32 U.S. country dynamics
Fig. 33 U.S. continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 34 Canada country dynamics
Fig. 35 Canada continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 36 Mexico country dynamics
Fig. 37 Mexico continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 38 Europe continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 39 UK country dynamics
Fig. 40 UK continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 41 Germany country dynamics
Fig. 42 Germany continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 43 France country dynamics
Fig. 44 France continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 45 Italy country dynamics
Fig. 46 Italy continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 47 Spain country dynamics
Fig. 48 Spain continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 49 Denmark country dynamics
Fig. 50 Denmark continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 51 Sweden country dynamics
Fig. 52 Sweden continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 53 Norway country dynamics
Fig. 54 Norway continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 56 Japan country dynamics
Fig. 57 Japan continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 58 China country dynamics
Fig. 59 China continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 60 India country dynamics
Fig. 61 India continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 62 Australia country dynamics
Fig. 63 Australia continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 64 South Korea country dynamics
Fig. 65 South Korea continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 66 Thailand country dynamics
Fig. 67 Thailand continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 68 Latin America continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 69 Brazil country dynamics
Fig. 70 Brazil continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 71 Argentina country dynamics
Fig. 72 Argentina continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 73 MEA continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 74 South Africa country dynamics
Fig. 75 South Africa continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia country dynamics
Fig. 77 Saudi Arabia continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 78 UAE country dynamics
Fig. 79 UAE continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 80 Kuwait Key country dynamics
Fig. 81 Kuwait continuous subcutaneous insulin infusion market, 2018 - 2030 (USD Million)
Fig. 82 Company categorization
Fig. 83 Company market position analysis
Fig. 84 Strategic framework

Companies Mentioned

  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • ZEALAND PHARMA
  • CeQur Simplicity
  • Insulet Corporation
  • YPSOMED
  • B. Braun SE
  • BD (Becton, Dickinson and Company)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 674.8 million
Forecasted Market Value ( USD ) by 2030 $ 1140 million
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030 - Product Image

Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
UK Insulin Drugs And Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

UK Insulin Drugs And Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 70 Pages
  • United Kingdom
From
Europe Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

Europe Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 80 Pages
  • Europe
From
Middle East and Africa Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

Middle East and Africa Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 80 Pages
  • Africa, Middle East
From
North America Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

North America Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 112 Pages
  • North America
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.